Table 2

Summary of results of between-group SMD for primary outcomes of included randomised controlled trials

StudyTitle, journalBaseline M (SD) PTBaseline M (SD) controlPrimary FU M (SD) PTPrimary FU M (SD) controlOther FU M (SD) PTOther FU M (SD) controlDid primary FU score reach ?Proportion of participants with FU score greater than PASS scorePT group change score (primary outcome primary end point)Control group change score primary outcome primary end point)Did primary change score reach MIC?Between-group SMD (95% CI) for primary outcomes (positive SMD favours PT intervention)
Studiescomparing physiotherapist-led treatment with sham or control treatment innon-surgical cohorts
Grant, et al 2017 34 The HAPI ‘Hip Arthroscopy Pre-habilitation
Intervention’ study: does prehabilitation affect the outcomes in patients undergoing hip arthroscopy for femoroacetabular impingement?
NAHS 60 (23.6)NAHS 54.4 (24.5)NAHS 56.3 (18.5)NAHS 48.8 (20.6)NANAUnknownNAAuthor did not provide dataAuthor did not provide dataUnknownNAHS NC
Harris-Hayes, et al 39 Movement pattern trainingto improve function in people with chronic hip joint pain: a feasibility randomised clinic trialHOOS-Pain 78.2 (12.3)
HOOS-QOL 65.1 (13.0)
HOOS-Pain 73.9 (13.8)
HOOS-QOL 55.3 (19.2)
HOOS-Pain 81.5 (13.2)
HOOS-QOL 71.3 (18.3)
HOOS-Pain 75.8 (13.4)
HOOS-QOL 63.1 (19.7)
NANANo
No
5/16 (31%)
4/16 (25%)
HOOS-Pain 3.3 (9.9)
HOOS-QOL 6.2 (10.6)
HOOS-Pain 1.9 (10.4))
HOOS-QOL 7.8 (11.8)
No
No
HOOS-Pain 0.13 (−0.53 to 0.80)
HOOS-QOL −0.14 (−0.80 to 0.52)
Kemp, et al 40 The Physiotherapy for Femoroacetabular Impingement Rehabilitation Study: a pilot randomised controlled trialIHOT 60 (26)
HOOS-QOL 54 (21)
IHOT 56 (25)
HOOS-QOL 50 (17)
IHOT 87 (12)
HOOS-QOL 76 (13)
IHOT 67 (24)
HOOS-QOL 62 (24)
NANAYes
No
6/7 (86%)
2/7 (29%)
IHOT 22 (26)
HOOS-QOL 11 (8)
IHOT 11 (8)
HOOS-QOL 12 (8)
Yes
Yes
IHOT 0.68 (−0.22 to 1.58)
HOOS-QOL 0.54 (−0.36 to 1.43)
Smeatham, et al 2017 37 Does treatment by a specialist physiotherapist change pain and function in young adults with symptoms from femoroacetabular impingement? A pilot project for a randomised controlled trialNAHS Total 50.1 (19.1)NAHS Total 54.4 (13.3)NAHS Total 62.2 (16.1)NAHS Total 55.2 (15.0)NANAUnknownNANAHS Total 12.7 (19.1)NAHS Total 1.8 (13.3)UnknownNAHS Total 0.64 (−0.09 to 1.38)
Wright, et al 2016 38 Non-operative management of femoroacetabular impingement: a prospective, randomised controlled clinical trial pilot studyHOS-ADL 74.3 (13.1)
HOS-Sport 59.4 (18.0)
HOS-ADL 73.8 (11.3)
HOS-Sport 51.4 (16.2)
HOS-ADL 81.1 (20.3)
HOS-Sport 70.0 (29.3)
HOS-ADL 85.1 (6.0)
HOS-Sport 72.4 (15.3)
NANANo
No
2/8 (25%)
2/8 (25%)
HOS-ADL 6.4 (13.1)
HOS-Sport 10.6 (18)
HOS-ADL 11.4 (11.3)
HOS-Sport 21.0 (16.2)
No
No
HOS-ADL −0.34 (−1.37 to 0.68)
HOS-Sport −0.57 (−1.61 to −0.47)
Studiescomparing physiotherapist-led treatment with sham or control treatment in postsurgicalcohorts
Bennell, et al 2017 33 Efficacy of adding a physiotherapy rehabilitation programme to arthroscopic management of femoroacetabular impingement syndrome: a randomised controlled trial (FAIR)IHOT-33 40.9 (15.7)
HOS-Sport 50.9 (17.1)
IHOT-33 42.0 (17.5)
HOS-Sport 52.1 (16.7)
IHOT-33 78.8 (17.8)
HOS-Sport 83.6 (18.1)
IHOT-33 66.4 (20.5)
HOS-Sport 70.8 (18.6)
IHOT-33 84.4 (12.1)
HOS-Sport 85.0 (17.8)
IHOT-33 78.1 (16.4)
HOS-Sport 86.0 (12.4)
Yes
No
10/11 (90%)
3/11 (27%)
IHOT 38.0 (14.0)
HOS-Sport 32.7 (18.5)
IHOT 22.5 (22.3)
HOS-Sport 16.7 (24.5)
Yes
No
IHOT 0.80 (0.05 to 1.55)
HOS-Sport 0.71 (−0.03 to 1.45)
Kemp, et al 201836 A pilot randomised clinical trial of physiotherapy (manual therapy, exercise and education) for early onset hip osteoarthritis posthip arthroscopyHOOS-QOL 49.0 (25.0)
IHOT 62.6 (23.7)
HOOS-QOL 51.0 (15.5)
IHOT 58.1 (17.3))
HOOS-QOL 51 (23)
IHOT 64 (18)
HOOS-QOL 55 (20)
IHOT 57 (23)
NANANo
Yes
1/9 (11%)
6/9 (67%)
IHOT-33 7 (23)
HOOS-Pain 10(17)
IHOT-33 −4(24)
HOOS-Pain −2(17)
No
No
IHOT 0.45 (−0.53 to 1.43)
HOOS-QOL 0.67 (−0.33 to 1.67)
Studies comparing physiotherapist-led treatment with hip arthroscopy surgery
Griffin, et al 2018 7 Hip arthroscopy vs best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): a multicentre randomised controlled trialIHOT-33 35.6 (18.2)IHOT-33 39.2 (20.9)IHOT-33 49.7 (25)IHOT-33 58.8 (27)IHOT-33 45.6 (23)IHOT-33 46.6 (25)No60/162 (37%)IHOT-33 14.1 (25)IHOT-33 19.3 (27)YesIHOT-33 −0.21 (−0.43 to 0.01)
Mansell, et al 2018 8 Arthroscopic surgery or physical therapy for patients with femoroacetabular impingement syndromeHOS-ADL 64.6 (14.2)
HOS-Sport 53.2 (16.8)
IHOT 29.4 (16.1)
HOS-ADL 65.6 (15.2)
HOS-Sport 52.1 (18.1)
IHOT 28.5 (16.1)
HOS-ADL 73.1 (37.1)
HOS-Sport 57.1 (29.7)
IHOT 44.9 (29.0)
HOS-ADL 68.4 (22.3)
HOS-Sport 43.4 (29.3)
IHOT 51.2 (28.1)
HOS-ADL 6M 68.4 (18.1)
HOS-Sport 6M 53.1 (27.8)
IHOT 6M 37.5 (27.7)
HOS-ADL 12M 72.5 (27.8)
HOS-Sport 12M 52.4 (27.8)
IHOT 12M 43.9 (29.3)
HOS-ADL 6M 68.5 (18.7)
HOS-Sport 6M 45.2 (28.3)
IHOT 6M 43.8 (27.1)
HOS-ADL 12M 67.7 (19.7)
HOS-Sport 12M 51.8 (29.7)
IHOT 12M 48.9 (29.0)
No
No
No
8/33 (24%)
4/33 (12%)
11/33 (33%)
HOS-ADL 12.1 (34.0)
HOS-Sport 9.1 (47.3)
IHOT NR
HOS-ADL 18.2 (32.9)
HOS-Sport 11.3 (45.6)
IHOT NR
Yes
No
HOS-ADL −0.18 (−0.64 to 0.28)
HOS-Sport −0.05 (−0.50 to 0.41)
IHOT NC
Palmer, et al 2019 41 Arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of symptomatic femoroacetabular impingement: multicentre randomised controlled trialHOS-ADL 65.7 (18.9)HOS-ADL 66.1 (18.5)HOS-ADL 69.2 (19.1)HOS-ADL 78.4 (19.9)NANANo6/88 (7%)HOS-ADL 69.2 (19.1)*HOS-ADL 78.4 (19.9)*NoHOS-ADL −0.47 (−0.76 to −0.18)
  • *Data reported as follow-up score rather than change score.

  • ADL, activity of daily living; ER, external rotation; FABER, flexion-abduction-external rotation test; FADIR, flexion-adduction-internal rotation test; FU, follow-up time point; HAGOS, Copenhagen Hip and Groin Outcome Score; HHS, Harris Hip Score; HOOS, hip osteoarthritis disability outcome score; HOS, Hip Outcome Score; HSAS, hip sport and activity score; IHOT, International Hip Outcome Tool; IR, internal rotation; LEFS, lower extremity functional scale; 12M, 12-month follow-up; M, mean SD; 6M, 6-month follow-up; MIC, minimal important change; NA, not applicable; NAHS, Non-Arthritic Hip Score; NC, not calculated (insufficient data); NPRS, Numeric Pain Rating Scale; NR, not reported; PA, physical activity; PASS, Patient Acceptable State Score; PT, physiotherapy/physical therapy; QOL, quality of life; ROM, range of motion; SANE, single assessment numeric evaluation; SMD, standardised mean difference; VAS, Visual Analogue Scale.